References
-
1
Wong R S, Temes R T, Follis F M. et al .
Multiple polyposis and adenocarcinoma arising in Barrett’s esophagus.
Ann Thorac Surg.
1996;
61
216-218
-
2
Dolan K, Garde J, Walker S J. et al .
LOH at the sites of the DCC, APC, and TP53 tumor suppressor genes occurs in Barrett’s metaplasia and dysplasia adjacent to adenocarcinoma of the esophagus.
Hum Pathol.
1999;
30
1508-1514
-
3
Reddy B S, Rao C V, Seibert K.
Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis.
Cancer Res.
1996;
56
4566-4569
-
4
Kawamori T, Rao C V, Seibert K. et al .
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
Cancer Res.
1998;
58
409-412
-
5
Funkhouser E M, Sharp G B.
Aspirin and reduced risk of esophageal carcinoma.
Cancer.
1995;
76
1116-1119
-
6
Schreinemachers D M, Everson R B.
Aspirin use and lung, colon, and breast cancer incidence in a prospective study.
Epidemiology.
1994;
5
138-146
-
7
Zimmermann K C, Sarbia M, Weber A A. et al .
Cyclooxygenase-2 expression in human esophageal carcinoma.
Cancer Res.
1999;
59
198-204
-
8
Atherfold P, Obszynska A, Jankowski J.
Gastrin, the Janus peptide, induces pleiomorphic changes associated with Barrett’s metaplasia [abstract].
Gastroenterology.
2005;
128
A232
-
9
Singh P, Velasco M, Given R. et al .
Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen.
Gastroenterology.
2000;
119
162-171
-
10
Watson S A, Smith A M.
Hypergastrinemia promotes adenoma progression in the APC (Min-/+) mouse model of familial adenomatous polyposis.
Cancer Res.
2001;
61
625-631
-
11
Watson S A, Morris T M, McWilliams D F. et al .
Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence.
Br J Cancer.
2002;
87
567-573
-
12
Ottewell P D, Watson A J, Wang T C. et al .
Progastrin stimulates murine colonic epithelial mitosis after DNA damage.
Gastroenterology.
2003;
124
1348-1357
-
13
Fitzgerald R C.
Complex diseases in gastroenterology and hepatology: GERD, Barrett’s, and esophageal adenocarcinoma.
Clin Gastroenterol Hepatol.
2005;
3
529-537
-
14
Hall I P.
Expression profiling: fishing and chips.
Gut.
2004;
53
917-918
H. C. Wolfsen, M. D.
Division of Gastroenterology and HepatologyMayo Clinic
4500 San Pablo RoadJacksonvilleFlorida 32224 USA
Fax: +1-904-953-7260
Email: pdt@mayo.edu
